US › Healthcare

Burning Rock Biotech Ltd (BNR)

US · Healthcare · Diagnostics & Research

$12.90-17.31%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$134.9M

Revenue YoY

-9.2%

Net profit

$-18.4M

EPS

$-0.20

Net margin

-13.7%

Key statistics

Market cap

$160.3M

Forward P/E

0.0

P/B

2.09

Book value

$6.82

EPS (TTM)

$-0.79

52-week high

$41.72

52-week low

$6.79

50-day MA

$12.04

200-day MA

$17.12

Beta

1.29

Analyst view

with an average price target of $4.03.

Shareholding

Institutions

47.19%

Largest institutional holders

Fund	Stake
Kynam Capital Management, LP	11.74%
CRCM LP	4.02%
Renaissance Technologies Corp	0.50%
Amova Asset Management Americas, Inc	0.28%
Sumitomo Mitsui Trust Group Inc	0.28%
Bank of America Corp	0.28%
Citadel Advisors Llc	0.26%
HSG Holding Ltd	0.20%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Burning Rock Biotech Ltd — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.